enVVeno Medical (NVNO) Stock: Buy, Sell, or Hold?
NVNO - enVVeno Medical Corporation Common Stock
$6.74
0.03 (0.45%)
▲
5d:
-12.47%
30d:
-23.5%
90d:
-35.19%
WAIT
LOW Confidence
Analysis Updated: Oct 27, 2026 12:00 AM ET
Earnings: Oct 30, 2026
1d
Get Alerted When NVNO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: NVNO is down 12.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: NVNO is down 12.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: NVNO is currently trading at $6.74, which is considered oversold relative to its 30-day fair value range of $7.29 to $8.74.
Technical Outlook: Technically, NVNO is in a strong downtrend. Immediate support is located at $6.52, while resistance sits at $8.45.
Market Sentiment: NVNO scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $30.00 (+345.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NVNO is in a strong downtrend. Immediate support is located at $6.52, while resistance sits at $8.45.
Market Sentiment: NVNO scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $30.00 (+345.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$7.29 -
$8.74
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (33/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 345.1% below Wall St target ($30.00)
- WARNING: Composite score 50/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$7.29 -
$8.74
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$6.52
Resistance Level
$8.45
Current Trend
Strong Downtrend
Technical data as of
Oct 27, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.08
Wall Street Target
$30.00
(+345.1%)
Share & Embed Analysis
Last updated: October 28, 2026 1:43 AM ET
Data refreshes hourly during market hours. Next update: 2:43 AM
Data refreshes hourly during market hours. Next update: 2:43 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NVNO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$96 | 50 HOLD |
|
BSX
Boston Scientific Corp |
STRONG BUY
30 analysts |
$58 | 51 HOLD |
|
MDT
Medtronic PLC |
BUY
30 analysts |
$105 | 52 HOLD |
|
IRTC
iRhythm Technologies Inc |
STRONG BUY
16 analysts |
$171 | 44 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
22 analysts |
$83 | 40 HOLD |
